{"organizations": [], "uuid": "ade9b44886bf4170b14131ccdc20c305fd191540", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-loxo-oncology-completes-rolling-su/brief-loxo-oncology-completes-rolling-submission-of-new-drug-application-to-u-s-food-and-drug-administration-idUSASC09TKA", "country": "US", "domain_rank": 408, "title": "BRIEF-Loxo Oncology Completes Rolling Submission Of New Drug Application To U.S. Food And Drug Administration", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-26T13:53:00.000+03:00", "replies_count": 0, "uuid": "ade9b44886bf4170b14131ccdc20c305fd191540"}, "author": "", "url": "https://www.reuters.com/article/brief-loxo-oncology-completes-rolling-su/brief-loxo-oncology-completes-rolling-submission-of-new-drug-application-to-u-s-food-and-drug-administration-idUSASC09TKA", "ord_in_thread": 0, "title": "BRIEF-Loxo Oncology Completes Rolling Submission Of New Drug Application To U.S. Food And Drug Administration", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "u.s. food and drug administration reuters staff", "sentiment": "none"}, {"name": "reuters) - loxo oncology inc", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 26, 2018 / 10:55 AM / Updated 20 minutes ago BRIEF-Loxo Oncology Completes Rolling Submission Of New Drug Application To U.S. Food And Drug Administration Reuters Staff 1 Min Read March 26 (Reuters) - Loxo Oncology Inc: * LOXO ONCOLOGY COMPLETES ROLLING SUBMISSION OF NEW DRUG APPLICATION TO U.S. FOOD AND DRUG ADMINISTRATION FOR LAROTRECTINIB FOR THE TREATMENT OF TRK FUSION CANCER Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)", "external_links": [], "published": "2018-03-26T13:53:00.000+03:00", "crawled": "2018-03-26T14:25:00.025+03:00", "highlightTitle": ""}